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Background: This study evaluates the time-dependent pro-inflammatory response of the model human lung
epithelial cells (A549) to industrially relevant zinc oxide nanoparticles (ZnO NPs). In terms of toxicity, ZnO-NPs are
categorised into the group of high toxicity nanomaterials. However information on pro-inflammatory potential of
these NPs at sub-toxic concentrations is limited. Understanding how cellular defense mechanisms function in the
presence of sub-cytotoxic concentrations of these NPs is vital. Moreover, there is an urgent need for additional
in vivo studies addressing pulmonary toxicity due to accidental inhalation of ZnO NPs.
Results: Exposure to sub-cytotoxic ZnO NP concentrations (20 μg/mL) induced significant up-regulation of mRNA
for the pro-inflammatory cytokine IL-8 and redox stress marker heme oxygenase-1, along with increased release of
IL-8. The highest pro-inflammatory response was recorded after 4 to 6 hr exposure to ZnO NPs over a 24 hr period.
Pre-treatment of A549 cells with the sulfhydryl antioxidant N-acetyl cysteine (at 5 mM) resulted in significant reduction
of the up-regulation of inflammatory markers, confirming the role of reactive oxygen species in the observed
immunomodulatory effects, independent of cytotoxicity. Furthermore, we report for the first time that, intranasal
instillation of a single dose (5 mg/kg) of pristine or surfactant-dispersed ZnO NPs can cause pulmonary inflammation,
already after 24 hr in a murine model. This was confirmed by up-regulation of eotaxin mRNA in the lung tissue and
release of pro-inflammatory cytokines in the sera of mice exposed to ZnO NPs.
Conclusion: Our study highlights that even at sub-cytotoxic doses ZnO NPs can stimulate a strong inflammatory and
antioxidant response in A549 cells. ZnO NP mediated cytotoxicity may be the outcome of failure of cellular redox
machinery to contain excessive ROS formation. Moreover exposure to a single but relatively high dose of ZnO NPs via
intranasal instillation may provoke acute pulmonary inflammatory reactions in vivo.
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Engineered zinc oxide nanoparticles (ZnO) NPs offer
versatility and unique physicochemical properties that
have a vast array of commercial applications, and are
widely used in cosmetics and sunscreens, because of their
excellent UV filtering properties and aesthetic appeal [1].
Interestingly, despite high production volumes and a
broad application base, there is always a possibility of* Correspondence: andreas.lopata@jcu.edu.au
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unless otherwise stated.accidental exposure to NPs. This can result in uninten-
tional side-effects caused due to the propensity of these
materials to demonstrate biological reactivity [2]. One
particular concern is exposure to high concentrations of
ZnO NPs via inhalation in the occupational setting,
where nanomaterials are manufactured or added to
products [3]. Improved understanding of how cells inter-
act to the presence of NPs in their micro-environment
can help ascertain either the toxic potential or usefulness
of these materials for future biomedical applications.
ZnO NP mediated cytotoxicity has been previously
reported in several in vitro test systems including im-
mune cells, lung epithelial cells, colorectal epithelialal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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have shown that ZnO NPs can cause cytotoxicity via
apoptosis [9-12] and also genotoxicity [13-15]. Despite
some contradictory reports, the main paradigm explain-
ing ZnO NP cytotoxicity appears to be their tendency to
dissolve, resulting in the generation of Zn2+ ions, with an
associated generation of reactive oxygen species (ROS)
[8,16]. Extracellular dissolution of ZnO NPs and release of
Zn2+ ions has been reported to induce cell death in hu-
man T-cell leukaemia (Jurkat) cells [17], mouse macro-
phage (Ana-1) cells [18] or apically-exposed rat alveolar
epithelial cell monolayers [19]. Recently, it was proposed
that ZnO cytotoxicity requires direct particle-cell contact
and uptake, resulting in the release of high intracellular
concentrations of Zn2+ ions from ZnO dissolution within
lysosomes and late endosomes [20-22]. This hypothesis
has also been suggested for the in vivo scenario where
intratracheally instilled ZnO NPs were shown to induce
eosinophilia, and pulmonary fibrosis in exposed rodents
[23] which may be mediated via ROS formation [24-26].
ZnO NPs inducing an overproduction of ROS can also
result in apoptosis in rat retinal ganglion cells, [12] but in
case of ZnO NP-exposed Ana-1 cells, contrasting results
were observed [18]. Apart from cytotoxicity, inflammatory
potential of ZnO NPs has also been investigated [3,27].
Zinc is an essential trace element and plays an important
role in regulating cellular metabolism [28,29]. Therefore,
it is also possible that increased exposure to ZnO NPs
may cause immunomodulation. Currently, there is a lack
of a clear understanding of how the inflammatory poten-
tial of ZnO NPs, their dissolution characteristics and sub-
sequent ROS generating capacity are interlinked together
particularly at the sub-cytotoxic level. Moreover, the
bio-reactivity of NPs may be greatly influenced by their
biological environment [2].
Systemic deposition of NPs in vivo may lead to their
interaction with immune cells resulting in immunomodu-
latory consequences. Intratracheal instillation of ZnO NP
has been reported to cause classic pulmonary oxidative-
inflammatory responses [23,30-32]. Inhalation of ZnO
NPs may lead to their translocation to the central nervous
system and may also interfere with zinc homeostasis lead-
ing to pulmonary toxicity [33,34]. Intratracheal instillation
of NPs is not a route of exposure in the occupational
setting and can cause less homogenous and focally
distributed deposition of the nanomaterial in the lungs.
Conversely, intranasal instillation can be used to deliver
NPs to the upper as well as lower respiratory tracts. Al-
though intranasal instillation of ZnO NPs has been shown
to likely cause injury to the olfactory epithelium of
exposed rats, [35] probable pulmonary side-effects and
systemic inflammatory responses resulting from this route
of exposure have not been investigated before. Further-
more, additional in vivo studies are required to determine“no-observed-adverse-effect-levels” of accidental exposure
to NPs [36].
In the present study, we have assessed the immuno-
modulatory potential of industrially manufactured ZnO
NPs, focusing on three different particle sizes (30, 80 and
200 nm) and dispersal states using a commercial surfac-
tant to investigate the effect of aggregation. We have made
use of human lung epithelial (A549) cells for the in vitro
exposure study as they are representative of the alveolar
type II cells in lungs and are widely used in nanotoxicol-
ogy. In addition, based on the findings from our in vitro
study, we chose two ZnO NPs (pristine 30 nm and
surfactant-dispersed 30 nm) for an acute high dosage in-
tranasal exposure study in mice. The aims of the study
were 1) to systematically investigate the time-course re-
sponses over 24 hr of A549 cells exposed to sub-cytotoxic
levels of ZnO NPs, to further understand the kinetics and
elucidate the mechanisms underlying their observed im-
munomodulatory and cytotoxic effects, and 2) evaluate
the effects of an acute exposure of a single high dose of
ZnO NPs via the intranasal route of airway exposure
in vivo.
Results
Cytotoxicity profile
Cytotoxicity observed for all ZnO NPs was concentration
dependent and similar to ZnCl2. Surfactant-dispersed
80 nm ZnO NPs demonstrated greater cytotoxicity than
their pristine counterpart when comparing the effective
concentrations that produced 50% cell death (EC50)
(Figure 1A). Whereas, the cytotoxicity observed for the
pristine particulates was marginally greater (p < 0.05) than
the surfactant-dispersed 200 nm ZnO at the highest tested
concentration. Overall, the surfactant-dispersed 200 nm
ZnO particulates were found to be the least cytotoxic ma-
terial, achieving less than an EC25 response at the highest
tested dose (200 μg/mL). This surfactant by itself has
previously been shown to be non-cytotoxic over this same
dose-range [6]. LDH release was measured after 24 hr
exposure and the results were concentration dependent
(Figure 1B), but less sensitive than MTS, as all NPs up to
the maximum dose of 200 μg/mL showed a higher degree
of similarity in LDH release. LDH values were significantly
different to untreated control cells at 100 μg/mL, com-
pared to the MTS assay achieving statistical significance at
30 μg/mL.
Up-regulation of pro-inflammatory IL-8 and stress-responsive
HO-1 genes
Systematic investigation of HO-1 up-regulation as a
function of time revealed that, the activation started at
4 hr after exposure, peaked at 6 hr and had subsided by
24 hr, when compared to basal levels of HO-1 gene acti-
vation in untreated cells (Figure 2A). At 4 hr, HO-1 gene
Figure 1 Cytotoxicity profile of pristine and surfactant-dispersed
ZnO NPs after 24 hr exposure of human lung epithelial A549
cells, using the (A) MTS assay and (B) lactate dehydrogenase
release assays. Cytotoxicity was dependent on NP size and dispersal
state. Concentrations at or below the dotted line (MTS assay) and
beyond the dotted line (LDH release assay) were significantly different
from untreated control cells. Values are expressed as mean ± SEM
(n = 5 separate experiments).
Figure 2 ZnO NP mediated pro-inflammation in A549 cells
exposed to the sub-cytotoxic dose (20 μg/mL) over 24 hr. (A)
ZnO NP induced up-regulation of HO-1 mRNA indicative of a strong
antioxidant response in A549 cells. Highest HO-1 expression was seen at 6hr
which was a 30-fold increase in gene expression compared to untreated
cells at 6hr (p<0.001). Block bars compare the statistical significance between
pristine or surfactant-dispersed solutions for each ZnO NP size. (B)mRNA
over expression of the pro-inflammatory cytokine IL-8 in A549 cells
stimulated with 20 μg/mL of ZnO NPs at 1, 2, 4, 6 or 24hr. Maximum
expression of IL-8 gene was recorded at 4hr. (C) Release of pro-inflammatory
cytokine IL-8 by ZnO NP-exposed A549 cells at 1, 2, 4, 6 or 24 hr. Statistical
significance is shown in (B) and (C) compared to untreated cells at each
time point. *p<0.05,**<0.01,***p<0.001, ****p<0.0001. Data are expressed as
mean ±SEM of the fold levels compared to untreated controls at each time
point (n=3) separate experiments, each performed with triplicates).
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ranged from 6 to 12-fold. Overall, the highest up-
regulation at the 6 hr time point was induced by s30 ZnO
NPs, showing a 30-fold increase compared to untreated
cells. In decreasing order, HO-1 gene up-regulation at
6 hr was caused by: s30 > 80 ~ s80 ~ 200 > 30 > s200 ~
ZnCl2.
In the case of IL-8 gene expression, maximum stimu-
lation occurred at 4 hr exposure when compared to the
untreated control cells. IL-8 induction from all particu-
lates, except surfactant-treated 200 nm ZnO, ranged
from 5 to 7-fold that of the untreated control (Figure 2B).
However, after 24 hr exposure IL-8 gene expression
had returned to basal levels. Interestingly, ZnCl2 treated
cells, after 2 hr exposure, showed IL-8 gene up-regulation
that was significantly higher (p < 0.05) than all treatments
except s80 and s200 ZnO NPs. At all other time points
ZnCl2 induced IL-8 gene mRNA levels were similar to
Figure 3 Mitigation of the up-regulation of (A) HO-1 mRNA
expression and (B) IL-8 mRNA expression (C) IL-8 cytokine
release in antioxidant treated A549 cells after exposure to
ZnO NPs (20 μg/mL) for 6 hr. Statistical significance after
comparing no NAC or 5 mM NAC cells where *p < 0.05, ** < 0.01,
***p < 0.001, ****p < 0.0001. Data are expressed as mean ± SEM of the
fold levels compared to untreated controls at each time point (n = 3)
separate experiments, each performed with triplicates).
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ticles were the most potent at both 4 and 6 hr. Surfactant-
dispersed 200 nm particulates did not cause significant IL-
8 gene up-regulation. Moreover, replacement of the ZnO
NP containing cell culture medium with fresh
medium 1 hr after exposure to ZnO NPs did not
stimulate expression of HO-1 or IL-8 gene (data not
shown). This could be because, 1 hr is insufficient
time for significant cellular uptake of ZnO NPs, and
we have previously demonstrated the low solubility of
these NPs in cell culture medium. Clearly, the effects on
gene expression require cell uptake and intracellular
dissolution.
IL-8 release
A gradual increase in IL-8 levels in culture medium was
already apparent after 4 hr exposures for all NPs, except
pristine ZnO 80 and surfactant-dispersed 200. The lar-
gest IL-8 release was seen at 6 hr, where all particulates
showed at least 4 fold increases in IL-8 release, as com-
pared to the untreated control cells. (Figure 2C). IL-8
levels were not significantly altered at the earlier 1 and
2 hr time points for the ZnO NPs and particulates except
zinc.
Effect of sulfhydryl antioxidant
The highest mRNA expression for HO-1 and IL-8
genes was seen at 6 hr and 4 hr post-exposure, re-
spectively. To confirm the role of ROS in the ob-
served immunomodulatory responses, A549 cells were
pre-treated for 1 hr with 5 mM of NAC followed by
exposure to ZnO NPs for 6 hr (when IL-8 gene expres-
sion was also still marginally up-regulated and IL-8 re-
lease was progressively increasing). The concentration
of NAC used for this experiment did not induce cyto-
toxicity (108 ± 1.5% of control). Pre-treatment with
NAC dramatically reduced the ZnO-induced up-regulation
of mRNA expression levels for both HO-1 and IL-8
genes (Figure 3A & B). IL-8 gene expression increases
were not observed for s200 ZnO or ZnCl2-treated
cells. Levels of IL-8 release by NAC pre-treated A549
cells following exposure to ZnO and ZnCl2 were also
found to be lower than exposed cells without NAC
pre-treatment (Figure 3C).
Cell signalling
ZnO NPs were able to induce a rapid phosphorylation
of the p38 protein, a representative of the MAPK
signalling pathway cascade (Figure 4A). Exposure of
A549 cells to 20 μg/mL of ZnO particulates or ZnCl2
also induced phosphorylation of the p65 protein, which
is pivotal to NFκB signalling (Figure 4B). Characte-
ristic bands of phosphorylated p65 protein were ob-
served after 1 hr exposure to ZnO NPs or ZnCl2 andwere significantly stronger than those observed at 6 or
24 hr. Cells exposed to medium-only served as a negative
control.
Figure 4 Immunoblotting showing (A) phosphorylation of p38
protein, belonging to the redox-sensitive p38 Mitogen activated
protein kinase (MAPK) pathway and (B) p65 protein, involved in
NFκB activation, after exposing A549 cells to 20 μg/mL dose of
ZnO NPs.
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Figure 5 H&E staining of lung sections of mice treated with (A)
vehicle control, (B) LPS, (C) pristine 30 nm ZnO NPs and (D)
surfactant-dispersed 30 nm ZnO NPs via intratracheal instillation.
AV indicates the alveolar region of the lung. Red arrows indicate
haemorrhage and black arrows demonstrate thickened bronchial
walls.
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Figure 5 demonstrates haematoxylin and eosin staining of
the lung sections of the control group (Figure 5A) treated
with water showing normal morphology. In contrast, lung
sections of ZnO NP exposed mice (Figure 5C & D) show
severe inflammatory infiltration in the alveoli and peri
bronchial regions. The bronchial and vascular walls also
appear to be thickened (black arrows). A moderate level of
internal haemorrhage was also observed 24 hr after NP
challenge when comparing lung tissue section of control
mice (red arrows). RNA extracted from the lung tissue of
ZnO NP treated mice was used for qPCR analysis of key
pro-inflammatory markers. A significant up-regulation of
the eotaxin gene was observed in mice treated with
pristine 30 nm ZnO NPs compared to mice exposed to
vehicle control (Figure 6A). In contrast, at the end of
24 hr ZnO NPs did not cause significant up-regulation of
pro-inflammatory TNFα and MCP-1 genes in the lung tis-
sue of treated mice (Figure 6B & C). Cytokine profiling of
pooled mouse serum from each experimental group
revealed the presence of pro-inflammatory chemokines
(Figure 6D). Significant levels of MCP-1 protein were
detected in the pooled sera of mice treated with either
ZnO NP solutions. Pristine 30 nm ZnO NP treated miceshowed significantly elevated levels of the chemokine
IP-10, while 30 nm sZnO NPs caused an increase of
CCL5 (RANTES), known to recruit leukocytes to inflam-
matory sites. Interestingly, eotaxin was not detected in the
sera of ZnO NP exposed animals. Overall, the in vivo
inflammatory responses observed for NP treatment was
distinct from that observed for LPS treatment.
Discussion
Detailed knowledge of the ability of cells to deal with
both cytotoxic and sub-cytotoxic doses of ZnO NPs can
help in understanding mechanisms of cellular responses
to a range of concentrations of these NPs to which
workers may be exposed. The present study highlights
effect of physical parameters, such as dispersal state and
agglomerate size of ZnO NPs, along with duration of
contact with cells, on NP immunomodulatory and cyto-
toxic potential.
The cytotoxicity of ZnO NPs was quantified using
two different assays, the MTS assay which measures
the mitochondrial metabolism of metabolically-viable
cells, and the LDH release assay which quantifies the
release of this cytosolic enzyme from non-viable cells
after cell lysis. ZnO NPs cytotoxicity was concentration,
size and time dependent. These results are in agree-
ment with cytotoxic responses to identical NPs of human
monocytes and macrophages (THP-1 cells), as demonstra-
ted in previous studies by our group [6]. Surfactant-
dispersed and undispersed 200 nm particulates used in
our study displayed lower cytotoxicity at the highest tested
concentrations although the surfactant compound by itself
has been previously shown to be non-toxic over the same
concentration rage in vitro [6]. In the 80 nm size range,
AD
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Figure 6 qPCR analysis of mRNA levels for inflammatory markers (A) eotaxin, (B) MCP-1 and (C) TNFα in the lung tissues of treated
mice. (D) Proteome profile array of pro-inflammatory cytokines quantified in pooled sera from each experimental group. Statistical significance is
compared to vehicle control. Pink bars for A,B,C and dotted line for D represent the vehicle control. Data are expressed as mean ± SEM (n = 12)
from two separate experiments.
Saptarshi et al. Journal of Nanobiotechnology  (2015) 13:6 Page 6 of 11the surfactant-dispersed NPs were more cytotoxic than
their undispersed counterparts. Interestingly, for 30 nm
NPs, the MTS assay indicated that the pristine 30 nm
particles were most cytotoxic, whereas the LDH assay
indicated the surfactant-dispersed material was more
cytotoxic. It should be noted that the surfactant may
alter the membrane permeability of the cells to some
extent which could be responsible for the observed
inconsistencies in the cytotoxicity profiles of these
two assays. Additionally, the LDH assay was also less
sensitive than the MTS assay, as the maximum LDH
release for the highest concentration of ZnO NPs
used at 24 hr was found to be only 50% of LDH re-
lease from total cell lysis. Relating this to other mea-
sures of cell death, DAPI staining of A549 cells
exposed to a cytotoxic dose of ZnO NPs for 24 hr
(data not shown) revealed characteristic condensation
of the nuclear material, as is typically observed during
apoptosis, which has also been previously observed in
THP-1 monocytes [6].We next analysed how sub-cytotoxic doses of different
sizes and dispersal states of ZnO NPs affected A549 cells
over 1, 2, 4, 6 and 24 hr. At these low concentrations,
the data should not be confounded by factors expressed
during cell death and these should not contribute to
the expression of biomarkers used to assess the pro-
inflammatory potential of ZnO NPs in the present
study. Also, contamination of NP solutions with lipopoly-
saccharide (LPS) can occur and it is therefore important
to distinguish nanoparticle toxicity from endotoxin related
effects. We have previously demonstrated that the cyto-
toxic and inflammatory responses of the same ZnO NPs
or LPS were significantly different in an in vitro system
consisting of THP-1 monocytes [6]. Furthermore, A549
cells used in the present study are known to be relatively
insensitive to LPS. This further confirmed that the altered
immune responses of ZnO NP exposed A549 cells was
not due to LPS-contamination.
ROS generation has been extensively implicated as an
important driver of nanotoxicity [37]. However, whether
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causally linked needs further investigation. A three tiered
oxidative stress response has been previously described
for NP-mediated toxicity [16,38]. The lowest level of
oxidative stress is characterised by the induction of anti-
oxidant defence genes. This is followed by the second tier
where a pro-inflammatory response is initiated. HO-1 and
IL-8 genes are representatives of this oxidative stress/pro-
inflammatory paradigm. The oxidative stress-responsive
HO-1 is primarily involved in the conversion of heme
to biliverdin and has been also reported to have anti-
inflammatory properties [39]. In our study, we observed a
gradual increase in expression levels of HO-1 gene from
2 hr, reaching maximum activation at 6 hr and returning
to basal levels at 24 h. These results are in accordance
with studies showing similar results, with human endothe-
lial cells exposed to SiO2 NPs [40], and A549 cells exposed
to Fe3O4 magnetic NPs [41]. In our study, surfactant-
treated 30 nm ZnO NPs maximally induced HO-1 expres-
sion, compared to the other NPs studied. This may be
because of the enhanced accessibility of these NPs to the
cell surface due to the small size and improved dispersal,
which may have resulted in greater uptake and subsequent
intracellular release of zinc ions. This rapid uptake and
release would likely create an imbalance in the cellular
antioxidant capacity [42]. It is also worth reiterating that
the surfactant may alter membrane permeability to NPs to
some extent, which would also potentially increase uptake.
The HO-1 and IL-8 results indicate a strong antioxidant
response of exposed cells against the ROS generated due
to their interaction with ZnO NPs.
Airway epithelial cells offer an important physiological
barrier against inhaled matter, and are responsible for
releasing a number of crucial cytokines and chemokines.
The α chemokine IL-8 is a potent chemo attractant for
neutrophils and eosinophils, and a possible protagonist
in the progression of airway inflammation [43]. Sub-
cytotoxic doses (2 – 8 μg/mL) of ZnO NPs have previously
been shown to increase IL-8 mRNA expression and IL-8
release in exposed BEAS-2B cells [3]. Pro-inflammatory
effects resulting from exposure to a sub-cytotoxic dose of
ZnO NPs have included the release of IL-8 by nasal muco-
sal cells into the culture medium [14]. In the present study,
all tested ZnO NPs were capable of inducing significant
up-regulation of IL-8 mRNA in A549 cells, which was
maximal after 4 hr exposure compared to untreated cells.
Interestingly, the 200 nm ZnO particulates demonstrated a
similar response to the s30 ZnO NPs. This may be partially
because of the greater heterogeneity in the 200 nm ZnO
NPs, which also contains a proportion of both smaller and
larger sized particles. Moreover, while surfactant dispersal
allows the NPs to remain in solution for longer intervals,
pristine NPs tend to agglomerate and sediment rapidly,
resulting in enhanced cellular dosing, which may causeincreased activation of cellular mRNA, as has been pre-
viously reported [44]. Similar observations have been re-
ported for 100 or 20 nm ZnO NP treated HaCaT cells [45].
In conjunction with IL-8 mRNA up-regulation, we also
quantified the relative levels of IL-8 protein release into cell
culture medium. At low NP doses, A549 cells in our study
demonstrated increased expression of IL-8 involving
transcriptional activation of NFκB, followed by further
stabilisation of IL-8 mRNA by p38 mitogen activated
protein kinase pathway [43]. Transcriptional and post-
transcriptional regulation of ZnO NP-mediated over
expression of the IL-8 gene has previously been reported
for BEAS-2B cells, which required phosphorylation of
protein p65 [3,46]. Similarly, the p38 MAPK pathway is
known to be activated by a number of stimuli including
oxidative stress, which can lead to phosphorylation of the
p38 protein. In this study, ZnO NPs and ZnCl2 treatment
induced rapid phosphorylation of p65 (Ser536) and p38 in
treated A549 cells after 1 hr exposure, compared to un-
treated cells, and this returned to basal levels at 6 or
24 hr. Uptake of ZnO NPs may occur via endocytosis [46].
Once internalised into the acidic lysosomes, ZnO NPs
dissolution occurs, which can disrupt intracellular zinc
homeostasis [21,22]. We have previously demonstrated
low rates of dissolution in cell culture medium, both with
and without protein supplementation [6,47] (Additional
file 1: Table S1). It is therefore unlikely that extracellular
dissolution is the driving cause of the pro-inflammatory
signals observed for these NPs. Exposure of A549 cells to
ZnO NPs for 1 hr followed by washing and supplementing
cells with fresh medium and then a further incubation for
4 hr, did not stimulate mRNA over expression of the pro-
inflammatory cytokines. Taken together with the dissol-
ution data, indicates that direct continued contact of ZnO
NPs with the cells is essential. Furthermore, pre-treatment
of A549 cells with NAC not only was able to significantly
reduce up-regulation of both the HO-1 and IL-8 genes,
but also controlled the release of IL-8 protein. This con-
firmed participation of ROS in the development of the ob-
served tier 1 and 2 redox responses in A549 cells exposed
to a sub-cytotoxic concentration of ZnO NPs.
The lung environment represents a complex biological
system. Inhalation or intratracheal instillation of ZnO
NPs in rodents can induce increased polymorphonuclear
cell counts, eosinophilia and oxidative stress like symp-
toms [30,31,48]. Our analysis after intranasal instillation of
ZnO NPs showed results that were similar to the cytotoxic
patterns observed for A549 cells. ZnO NP treatment
resulted in substantial inflammatory infiltration into
the alveoli and peri-bronchial regions. Moderate amounts
of haemorrhage were also observed. Based on the histo-
pathological data we chose to analyse mRNA up regulation
in the lung tissue and systemic release of inflammatory
mediators 24 hr after exposure to the ZnO NP solutions.
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of mice treated with ZnO NPs, there was a significant up-
regulation of eotaxin mRNA in mice treated with pristine
30 nm ZnO NPs indicating a potential eosinophilia. The
discrepancies observed in the mRNA up regulation levels
of the pro-inflammatory genes and the release of the
same cytokines in the serum may be attributed to the
fact that the Zno NPs may have stressed other tissue
types besides the lung as previously reported by Gao
and co-workers [35]. The lung environment may pro-
mote dissolution of ZnO NPs, which might result in
lung injury [33]. ZnO NPs also caused a significant sys-
temic release of pro-inflammatory serum chemokines
including MCP-1, RANTES and IP-10, all associated
with the recruitment of inflammatory cells to sites of
inflammation. Cumulative inhaled ZnO NP doses of
10.9 mg/kg (306 μg/mouse) over 13 week exposure period
was shown to elicit minimal pulmonary inflammation
without causing significant release of pro-inflammatory
markers in a recent animal study [49]. The preliminary
results of our in vivo study highlight the inflammatory
potential of inhaled ZnO NPs via intranasal installation,
although the overall ZnO NP burden delivered is instant-
aneous and is relatively low with 5 mg/kg (84 μg/mouse).
This highlights that the route and rate at which ZnO NPs
are delivered in vivo may influence their toxic potential
rather than the dose delivered. Similar observations have
been previously suggested for poorly soluble titanium
dioxide NPs [50]. In contrast to the in vitro studies no
clear differences could be observed in the inflammatory
profile of the two differentially dispersed 30 nm ZnO NP
solutions. This may be explained by the complexity of the
lung environment in terms of its cellular and protein
diversity which may compound the bio-reactivity of NPs.
Future detailed studies analysing the long term exposure
of instilled NPs via the intranasal route are in progress.
Conclusions
In summary, we have shown that the presence of ZnO
NPs with low solubility in the cellular micro-environment
helps initiate a strong antioxidant response as evident by
the gradual up-regulation of the HO-1 gene. This is com-
plemented by increased IL-8 gene expression and subse-
quent release of this pro-inflammatory cytokine. These
immunological changes highlight the reactive nature of
ZnO NPs even when no immediate cytotoxicity is obser-
ved. Dispersal state and particle size influenced the overall
cytotoxicity and cellular responses of these NPs. NAC
pre-treatment of A549 cells confirmed a role for ROS gen-
eration as a result of the elevated intracellular Zn2+ and
subsequent phosphorylation of p65 and p38 transcription
factors. Consequently, ZnO NP mediated cytotoxicity may
be the outcome of failure of cellular redox machinery to
contain excessive ROS formation. Furthermore, we havefor the first time reported the potential of ZnO NPs to
cause pulmonary immunomodulation when exposed via
intranasal instillation. Our study provides a better under-
standing of the pro-inflammatory effects of interaction of
ZnO NPs with the cellular systems of the airways.
Methods
Nanoparticles
Industrially manufactured ZnO NPs and particulates
(30, 80 and 200 nm) were supplied by Micronisers Pty
Ltd (Melbourne, Australia). The 30 nm ZnO NPs cor-
responded to the OECD standard reference material
NM-112. Two different solutions of ZnO NPs were
used, namely pristine material and particles dispersed
with 5% by weight of sodium polyacrylate (Orotan 731
DP) surfactant dispersant (designated as “ZnO” or “sZnO”,
respectively). All particulate stock suspensions were pre-
pared in de-ionised water (MilliQ systems, Millipore).
Physical characterisation data estimating primary particle
size and particulate size before and after agglomeration in
cell culture medium, along with cryo-transmission elec-
tron microscopy images, have been previously published
[22]. Solubility of ZnO NPs in cell culture medium with
or without protein (10% fetal bovine serum) was assessed
using Varian Liberty Series II Inductively Coupled Plasma
Atomic Emission Spectrometer (Melbourne, Australia); as
previously described [6].
Cell culture and nanoparticle exposure
Human alveolar lung epithelial A549 cells obtained from
the American Type Culture Collection (ATCC, USA)
were cultured in RPMI-1640 medium (Sigma-Aldrich,
USA) supplemented with 10% fetal bovine serum, 1%
penicillin–streptomycin and L-glutamine. For the study
of cytotoxic effects, 10,000 cells in 100 μL were seeded
into 96-well tissue culture plates (Sarstedt, Germany).
After allowing for overnight attachment, the cells were
exposed to ZnO NP concentrations (0.2 – 200 μg/mL)
for 24 hr. For the study of mRNA up-regulation, release
of cytokines and immunoblotting experiments, 106 cells
per well seeded into 6-well tissue culture plates were
used. Subsequently cells were exposed to a dose of
20 μg/mL of the ZnO NPs for 1, 2, 4, 6 or 24 hr. ZnCl2
was used as a non-engineered form of zinc particulate
control.
Cytotoxicity assays
Viability of A549 cells was assessed via MTS (Promega
MTS CellTiter 96® aqueous kit, Promega, USA), and
lactate dehydrogenase release (LDH) (CytoTox 96®
Non-Radioactive Cytotoxicity Assay Promega, USA) as-
says. At the end of the 24 hr exposure period, 50 μL of the
supernatant was transferred to another 96-well flat-
bottom plate. The NP-containing media in the plates with
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MTS reagent and the plates were further incubated at
37°C for 3 hr and read at 490 nm (VersaMax, Molecular
Devices, USA). ZnO particulates with MTS reagent
alone provided readings of cell-free blank controls. The
50 μL supernatant sample was then mixed with an equal
amount of LDH substrate mix. Following incubation at
room temperature for 30 min, the absorbance was re-
corded at 490 nm. Supernatant from wells exposed to
5 μL lysis solution were used as the 100% LDH release
positive control. Wells containing cells exposed to
medium-only served as spontaneous LDH release con-
trol. Data were obtained from five independent experi-
ments, each performed in triplicate.
RNA isolation and quantitative-PCR (q-PCR)
Total RNA isolation from treated A549 cells was carried
out using the ISOLATE RNA Mini Kit (Bioline, USA) as
per manufacturer’s instructions. Concentrations of ex-
tracted RNA samples were determined using a Nanodrop
8000 spectrophotometer (Thermo Scientific, Germany)
and reverse transcribed into cDNA using the Tetro cDNA
Synthesis kit (Bioline, USA). Changes in expression levels
of the pro-inflammatory cytokine IL-8 and the oxidative
stress response enzyme heme oxygenase-1 (HO-1) were
determined using q-PCR using the SsoAdvanced ™SYBR ®
Green Supermix (BioRad, USA) reaction mixture contain-
ing specific primers. Primers used were: HO-1 primers,
sense 5′-CGCCTTCCTGCTCAACATT-3′ and antisense
5′-TGTGTTCCTCTGTCAGCATCAC-3′. IL-8: sense 5′-
GGCACAAACTTTCAGAGACAG-3′ and antisense 5′-
ACACAGAGCTGCAGAAATCAGG-3′. The housekeeping
gene used was ubiquitin, sense 5′-GCAAGCTACAAT
AATGGGGC-3′ and antisense 5′- TGTAAATGCAAC
CTTAGGTGGT-3′. q-PCR was performed using the
Piko Real real-time PCR System (Thermo Scientific,
Germany). Thermal cycle parameters used were 7 min
at 95°C, followed by 45 cycles (95°C, 15 sec; 55°C,
15 sec; 72°C, 30 sec). Data were analysed using relative
quantitation.
IL-8 release
ZnO NPs induced IL-8 release was assessed using enzyme-
linked immunosorbant assay (ELISA) in cell supernatants
of A549 cells exposed to ZnO NPs using the BD OptEIA
human IL-8 ELISA kit (BD Systems, USA) as per manufac-
turer’s instructions. Three independent experiments were
performed, each with triplicate samples.
Effect of sulfhydryl antioxidant
A549 cells were pre-treated with 5 mM of the sulfhydryl
antioxidant N-acetylcysteine (NAC) (Sigma-Aldrich, USA)
for 1 hr before exposure to ZnO NPs. The NAC dose wasconfirmed to be non-cytotoxic to A549 cells using the
MTS assay.
Cell signalling: immunoblotting for NFκB, p-38 MAPK
pathway activation
At the end of the in vitro NP exposures for 1, 6 or 24 hr,
the cells were washed with PBS and lysed using NP40
cell lysis buffer (Invitrogen, USA) supplemented with
1 mM phenylmethylsulfonyl fluoride (PMSF) and protease
inhibitor cocktail (Sigma-Aldrich, USA). The cell lysates
obtained were the subjected to SDS-PAGE followed by
transfer onto a nitrocellulose membrane using the semi-
dry transfer system (BioRad, USA). After blocking with 1%
Superblock (Sigma-Aldrich, USA) blocking solution for
1 hr, the membranes were probed overnight with specific
primary antibodies: Phospho p38(Thr180/Tyr182), p38
MAPK antibody, along with phospho-NFκB p65(Ser536)
or NFκB p65 antibodies (Cell Signalling, USA), followed
by washing with PBS. Proteins were detected using horse-
radish peroxidase-tagged secondary antibodies (Cell Sig-
nalling, USA) and enhanced chemiluminescence substrate
(Pierce, USA), followed by exposure to photographic film
(GE Healthcare, Australia).
Intranasal instillation of ZnO NPs in mice
Female Balb/c mice (6–8 weeks old) purchased from the
Animal Resource Centre (WA, Australia) were randomly
assigned to four groups (n = 12) based on body weight
(14–19 gm). 30 nm pristine and surfactant-dispersed
ZnO NP solutions were prepared in sterile water. The
dose used for the study was 5 mg/kg (body weight).
50 μL of the dose was delivered into each nostril of the
mice held in supine position, using a 200 μL pipette tip.
Two out of the four experimental groups served as con-
trols including groups treated with a non-lethal dose of
0.5 mg/kg lipopolysaccharide (LPS) or water (vehicle
control). At the end of 24 hr exposure period mice were
killed and peripheral blood and lungs harvested from
each animal.
Serum prepared from the collected blood samples was
pooled for animals from each group and used for the
mouse proteome array (R&D Biosystems) as per manufac-
turer’s instructions. Small sections of the tissue obtained
were also used for RNA extraction and quantification of
mRNA levels of pro-inflammatory markers including:
eotaxin, sense 5′-AGAGGCTGAGATCCAAGCAG-3′ and
antisense 5′-CAGATCTCTTTGCCCAACCT-3′, TNFα,
sense 5′- TACTGAACTTCGGGGTGATTGGTCC-3′ and
antisense 5′-CAGCCTTGTCCCTTGAAGAGAACC-3′,
MCP-1, sense 5′-ACCACAGTCCATGCCATCAC-3′
and antisense 5′-TTGAGGTGGTTGTGGAAAAG-3′
and the housekeeping gene used was β actin, sense 5′-
CGAGCGTGGCTACAGCTTCA-3′ and antisense 5′-AG
GAAGAGGATGCGGCAGTG-3′. The remaining intact
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staining was performed on formalin-fixed lung sections
embedded in paraffin and sliced into 5 μm thick sec-
tions and examined under a light microscope. Animal
experiments were approved by the animal ethics com-
mittee at James Cook University.
Statistics
Data are presented as mean ± standard error of mean
(SEM) and was analysed using two way ANOVA for
cytotoxicity assays or one-way ANOVA for all other ana-
lyses, followed by Bonferroni post-hoc test (Prism 6.0,
GraphPad Software, USA), with a p value <0.05 consid-
ered as significant.
Additional file
Additional file 1: Table S1. Dissolution rates of ZnO NPs used in the
present study. ICP-AES was performed on dialysates of ZnO NPs 200 μg/mL
incubated in RPMI-1640 medium without protein for 24 hr. *Data are
adapted from (Feltis et al., 2012) and represent values obtained from
identical experiments carried out in the presence of 10% fetal bovine serum
supplemented RPMI-1640 medium.
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